Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
13,491
Total Claims
$1.4M
Drug Cost
692
Beneficiaries
$2,008
Cost/Patient
Risk Score Breakdown 9/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
-96%
Opioid rate vs peers
0.1% vs 2.2% avg
+42%
Cost per patient vs peers
$2,008 vs $1,411 avg
+9%
Brand preference vs peers
11.6% vs 10.6% avg
Opioid Prescribing
0.1%
Opioid Rate
12
Opioid Claims
$81
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 1,541 claims · $1.1M
Generic: 11,753 claims · $235K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 183 | $181K |
| Semaglutide | 119 | $175K |
| Sitagliptin Phosphate | 126 | $133K |
| Empagliflozin | 58 | $72K |
| Dulaglutide | 32 | $52K |
| Insulin Glargine,hum.Rec.Anlog | 83 | $48K |
| Rivaroxaban | 28 | $33K |
| Insulin Detemir | 20 | $29K |
| Mirabegron | 42 | $26K |
| Fluticasone/Umeclidin/Vilanter | 23 | $21K |
| Budesonide/Formoterol Fumarate | 44 | $21K |
| Semaglutide | 18 | $17K |
| Insulin Lispro | 12 | $16K |
| Sitagliptin Phos/Metformin Hcl | 12 | $15K |
| Atorvastatin Calcium | 922 | $13K |
Prescribing Profile
Patient Profile
75
Avg Age
60%
Female
1.23
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data